{
  "timestamp": "2026-01-05T07:12:16.938661",
  "agent_id": "medication_management",
  "phase": "complete",
  "input_data": null,
  "prompt": null,
  "llm_response": null,
  "output_data": {
    "clarification_needed": false,
    "clarification_question": null,
    "suggested_answer": null,
    "medications": [
      {
        "name": "Sertraline",
        "generic_name": "Sertraline",
        "brand_name": "Zoloft",
        "strength": "50 mg",
        "form": "Tablet",
        "route": "Oral",
        "frequency": "Daily",
        "indication": "Recurrent Major Depressive Disorder",
        "response": "Suboptimal/Poor response at 4 weeks (persistent anhedonia, fatigue, early morning awakening, passive suicidal ideation).",
        "adherence": "High ('taking it every day')",
        "side_effects": []
      }
    ],
    "changes_made": [
      {
        "medication": "Sertraline",
        "change_type": "Increase Dose",
        "rationale": "Suboptimal therapeutic response after 4 weeks at 50mg, necessitating dose escalation to 100mg to manage severe depressive symptoms (F33.1).",
        "new_dose": "100 mg daily"
      }
    ],
    "get_chat_summary": [
      "Medication Check: Patient reports taking *Sertraline* 50mg daily with high adherence.",
      "Response Status: Currently reporting poor efficacy after 4 weeks of use.",
      "Action Proposed: Increase *Sertraline* dose from 50mg to 100mg daily to address ongoing depressive severity.",
      "**PEER REVIEW**: The use of *Sertraline* is appropriate for the proposed diagnosis of *Recurrent Major Depressive Disorder* (F33.1). No diagnostic mismatch flagged."
    ]
  },
  "duration_ms": 5894,
  "error": null
}